NDAINHALATIONLIQUID
Approved
Jun 1995
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
3/8 — Basic
Drug data last refreshed 15h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ULTANE (sevoflurane) is a volatile general anesthetic administered by inhalation used to induce and maintain anesthesia in surgical and procedural settings. It belongs to the general anesthetic class and is a small molecule inhaled agent with rapid onset and offset properties.
LOE Approaching
As a mature product approaching loss of exclusivity with moderate competitive pressure (30%), the brand team is likely focused on lifecycle management and operational efficiency rather than aggressive growth initiatives.
Mechanism of Action
Pharmacologic Class:
General Anesthetic
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Ciprofol, Propofol and Sevoflurane for Postoperative Delirium in Elderly Brain Tumor Patients
Started Sep 2026
381 enrolled
Brain NeoplasmsDelirium - Postoperative
Simultaneous Measurement of EpicArdial and Microvascular ResisTance Via Angiographic FLOW Study
Started Jun 2026
620 enrolled
Non-obstructive Coronary DiseaseAcute or Chronic Coronary Artery Disease
Transition From Sevoflurane to Total Intravenous Anesthesia in Pediatric Patients
Started May 2026
50 enrolled
AnesthesiaPediatric AnesthesiaTotal Intravenous Anesthesia
Does Boredom With Simultaneously Perceived Pain Affect Pressure Pain Thresholds
Started Jan 2026
161 enrolled
Pain Thresholds
Sevoflurane Sedation in Patients With Septic Shock
Started Jan 2026
Worked on ULTANE at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.